ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Adlai Nortye Group Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026
$10.38−0.65 (-5.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Adlai Nortye has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Adlai Nortye filed with the SEC
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
EX-99.1 to Form 6-K
PROXY CARD FOR EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
EX-99.2 to Form 6-K
CONSTITUTION OF ADLAI NORTYE GROUP LTD. (REGISTERED ON JULY 29, 2026)
EX-99.1 to Form 6-K
PRESS RELEASE OF THE REGISTRANT, DATED APRIL 16, 2026
EX-99.1 to Form 6-K
FORM OF SECURITIES PURCHASE AGREEMENT
EX-99.2 to Form 6-K
ADLAI NORTYE LTD. APRIL 2026 CORPORATE PRESENTATION
EX-99.3 to Form 6-K
PRESS RELEASE, DATED FEBRUARY 12, 2026
EX-99.1 to Form 6-K
PRESS RELEASE OF THE REGISTRANT, DATED FEBRUARY 3, 2026
EX-99.1 to Form 6-K
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
EX-99.1 to Form 6-K
PROXY CARD FOR EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
EX-99.2 to Form 6-K
LETTER OF FORVIS MAZARS, LLP DATED FEBRUARY 14, 2025
EX-99.1 to Form 6-K
First Half 2024 Financial Results and Highlights Recent Operational Progress
EX-99.1 to Form 6-K
U.S. Securities and Exchange Commission
EX-99.1 to Form 6-K
Adlai Nortye Announces Appointment of Dr. Archie
EX-99.1 to Form 6-K